(Total Views: 377)
Posted On: 06/01/2020 1:15:15 PM
Post# of 11803
Quote:
Our 12-month business objectives include:
.
1. The practice of specializing in the distribution of GenUltimate! and
PetSure! and GenUltimate! 4Pets products, and the completion of the
GenViro!, GenChoice!, and GenUltimate! TBG products. We also intend to add several brand-name medical diagnostic and medical disposable products, lancets through our Firefly! product, as well as several lines of insulin syringes and pen needles
From Q1 Report P.14
https://backend.otcmarkets.com/otcapi/company...85/content
The global Diabetes Injection Pens market is valued at 4243.8 million US$ in 2020 is expected to reach 5639.9 million US$ by the end of 2026, growing at a CAGR of 4.1% during 2021-2026.
https://3wnews.org/uncategorised/1097641/diab...st-report/
Piece by piece DECN is enlarging its portfolio...
(2)
(0)
